Associations of Homeostatic Model Assessment for Insulin Resistance Trajectories With Cardiovascular Disease Incidence and Mortality
Arteriosclerosis, Thrombosis, and Vascular Biology · 2023-09 · 43 (9) · 1719-1728
DOI: 10.1161/atvbaha.123.319200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023-09. Verfasst von Jun-Hyuk Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Republic of Korea (J.-H.L.). Hauptthemen laut MEDLINE: Cardiovascular Diseases, Insulin Resistance. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Whether trends in insulin resistance changes are related to the risk of cardiovascular disease (CVD) incidence and mortality remains unclear. We aimed to examine the association of homeostatic model assessment for insulin resistance (HOMA-IR) trajectories with CVD incidence and mortality.
Methods
Data from 6755 adults aged 40 to 69 years in the Korea Epidemiology and Genome Study were analyzed. During the exposure period (2001–2006), participants were classified into the increasing HOMA-IR trajectory group and the stable HOMA-IR trajectory group using a latent class mixture model. During the event accrual period (2007–2018), information about CVD and mortality were collected.
Results
During the median 9.83-year event accrual period, there were 379 (5.6%) new-onset CVD, 535 (7.9%) all-cause mortality, 102 (1.5%) CVD mortality, and 47 (0.7%) major adverse cardiovascular event mortality cases. Compared with the stable HOMA-IR trajectory group, the fully adjusted hazard ratios (95% CIs) for the increasing HOMA-IR trajectory group were 1.59 (1.04–2.44) for incident CVD, 1.87 (1.30–2.69) for all-cause mortality, 2.33 (1.11–4.89) for CVD mortality, and 3.67 (1.38–9.76) for major adverse cardiovascular event mortality.
Conclusions
An increasing HOMA-IR appears to be independently and positively related to incident CVD, all-cause mortality, CVD mortality, and major adverse cardiovascular event mortality. Early lifestyle interventions for individuals with increasing HOMA-IR trend could be a practical strategy to prevent CVD and CVD mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Republic of Korea (J.-H.L.).
- Department of Medicine, Hanyang University Graduate School of Medicine, Seoul, Republic of Korea (J.-H.L.).
- Division of Cardiology, Department of Internal Medicine (B.J.), Yonsei University College of Medicine, Seoul, Republic of Korea.
- Biostatistics Collaboration Unit, Department of Research Affairs (S.J., H.S.L.), Yonsei University College of Medicine, Seoul, Republic of Korea.
Zitieren
APA
Lee, J. H., Jeon, S., Joung, B., Lee, H. S., & Kwon, Y. J. (2023). Associations of Homeostatic Model Assessment for Insulin Resistance Trajectories With Cardiovascular Disease Incidence and Mortality. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(9), 1719-1728. https://doi.org/10.1161/atvbaha.123.319200
Vancouver
Lee JH, Jeon S, Joung B, Lee HS, Kwon YJ. Associations of Homeostatic Model Assessment for Insulin Resistance Trajectories With Cardiovascular Disease Incidence and Mortality. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(9):1719-1728. doi:10.1161/atvbaha.123.319200
BibTeX
@article{Lee2023,
author = {Lee, Jun-Hyuk and Jeon, Soyoung and Joung, Boyoung and Lee, Hye Sun and Kwon, Yu-Jin},
title = {Associations of Homeostatic Model Assessment for Insulin Resistance Trajectories With Cardiovascular Disease Incidence and Mortality},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2023},
volume = {43},
number = {9},
pages = {1719--1728},
doi = {10.1161/atvbaha.123.319200}
}
EUVIMED